PLoS Neglected Tropical Diseases (Jun 2020)

The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers.

  • Denis Malvy,
  • Anne-Marie Taburet,
  • Xavier de Lamballerie,
  • France Mentre,
  • Fabrice Extramiana

DOI
https://doi.org/10.1371/journal.pntd.0008259
Journal volume & issue
Vol. 14, no. 6
p. e0008259

Abstract

Read online

No abstracts available.